Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker compared to those infected with SARS-CoV-2, the virus that causes COVID-19. In a study published today in ...

Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...

MIAMI, Feb. 23, 2026 (GLOBE NEWSWIRE) -- RESTEM – a clinical-stage biotechnology company that develops off-the-shelf, next-generation cell therapies designed to modulate the immune system, today ...

In a study published today in Science Translational Medicine, scientists from St. Jude Children's Research Hospital and The Jackson Laboratory (JAX) report that the two respiratory viruses trigger ...

Young infants hospitalized with respiratory syncytial virus (RSV) often become much sicker compared to those infected with SARS-CoV-2, the virus that causes COVID-19. In a study published today in ...

Fact check - There is no link between the discovery of cancer treatments and vaccines and the US leaving the WHO.

Oxford University Hospitals (OUH) is conducting a new trial, offering fresh hope to patients with relapsed blood cancer.

Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the development of intensive insulin therapy, continuous glucose monitoring, and hybrid ...

The central question is no longer whether we can innovate, but whether innovation can truly reach patients in time.

Stanford Medicine researchers have developed an experimental nasal spray vaccine that protected mice against SARS‑CoV‑2, influenza, and Streptococcus pneumoniae (a cause of bacterial pneumonia) with a ...

Acute Lymphocytic Leukemia (ALL) is a serious type of cancer that affects the blood and bone marrow. It moves very quickly, ...

By Pooja Toshniwal Paharia Preclinical studies increasingly place circular RNAs at the intersection of thermogenic programming and organelle stress control, raising the possibility that these stable ...